Yuki Nemoto Selected Research

Yuki Nemoto Research Topics

Disease

19	Neoplasms (Cancer) 01/2024 - 12/2015
17	Renal Cell Carcinoma (Grawitz Tumor) 02/2024 - 01/2021
5	Carcinoma (Carcinomatosis) 07/2023 - 03/2021
4	Melanoma (Melanoma, Malignant) 01/2024 - 12/2019
2	Disease Progression 02/2024 - 03/2021
2	Pain (Aches) 06/2023 - 06/2007
2	Hepatitis 01/2022 - 06/2021
1	Ulna Fractures 04/2024
1	Body Weight (Weight, Body) 01/2024
1	Rheumatoid Arthritis 11/2023
1	Intervertebral Disc Displacement (Herniated Disc) 06/2023
1	Wilms Tumor (Wilm's Tumor) 03/2022
1	Spondylosis 03/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Bacterial Infections (Bacterial Infection) 12/2021
1	Atrioventricular Block 10/2021
1	Anorexia 06/2021
1	Hemorrhage 03/2021
1	Wounds and Injuries (Trauma) 03/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2021
1	Hypoxia (Hypoxemia) 12/2020
1	Lymphoma (Lymphomas) 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2020
1	Hemangiosarcoma (Angiosarcoma) 01/2020
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2019
1	Disseminated Intravascular Coagulation 12/2019
1	Thrombophilia 12/2019
1	Histiocytic Sarcoma 06/2019
1	Reoviridae Infections 06/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2015

Drug/Important Bio-Agent (IBA)

12	Immune Checkpoint InhibitorsIBA 02/2024 - 12/2021
7	NivolumabIBA 06/2023 - 01/2021
6	IpilimumabIBA 06/2023 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2023
3	pembrolizumabIBA 07/2023 - 03/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 01/2021
2	Therapeutic UsesIBA 01/2024 - 10/2022
2	cabozantinibIBA 10/2023 - 06/2022
2	C-Reactive ProteinIBA 06/2023 - 01/2022
2	CopperIBA 01/2022 - 06/2021
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 10/2021 - 12/2015
2	Acridine OrangeIBA 10/2021 - 12/2015
1	ElementsIBA 04/2024
1	Rocuronium (Zemuron)FDA LinkGeneric 01/2024
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 11/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 06/2023
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2023
1	Sunitinib (Sutent)FDA Link 01/2023
1	Cystine (L-Cystine)IBA 06/2022
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 06/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2021
1	RhodanineIBA 06/2021
1	EnzymesIBA 06/2021
1	MetalsIBA 03/2021
1	Polymethyl Methacrylate (Sol)IBA 03/2021
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 03/2021
1	Mohs' pasteIBA 03/2021
1	PlatinumIBA 03/2021
1	AlbuminsIBA 03/2021
1	Hypoxia-Inducible Factor 1IBA 12/2020
1	haematoside synthetaseIBA 12/2020
1	GlycosphingolipidsIBA 12/2020
1	GangliosidesIBA 12/2020
1	G(M3) GangliosideIBA 12/2020
1	Monoclonal AntibodiesIBA 10/2020
1	Rituximab (Mabthera)FDA Link 10/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020
1	Complement System Proteins (Complement)IBA 10/2020
1	Prednisone (Sone)FDA LinkGeneric 10/2020
1	Vincristine (Oncovin)FDA LinkGeneric 10/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2020
1	tenovin-6IBA 01/2020
1	SirtuinsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 12/2019
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Dacarbazine (DIC)FDA LinkGeneric 12/2019
1	Thromboplastin (Tissue Factor)IBA 12/2019
1	Interferon Type IIBA 06/2019
1	AntibodiesIBA 04/2018

Therapy/Procedure

15	Therapeutics 02/2024 - 12/2015
4	Immunotherapy 10/2022 - 04/2018
3	Radiotherapy 05/2022 - 11/2015
3	Drug Therapy (Chemotherapy) 12/2021 - 10/2020
2	Photochemotherapy (Photodynamic Therapy) 10/2021 - 12/2015
1	Diskectomy (Discectomy) 06/2023
1	Nephrectomy 10/2022
1	Cytoreduction Surgical Procedures 05/2022
1	Laminectomy 03/2022
1	Molecular Targeted Therapy 01/2022
1	Anesthesia 10/2021
1	Cystectomy 03/2021
1	Oncolytic Virotherapy 12/2019
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2016
1	Analgesia 06/2007